Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced Thursday. Accredo is the specialty pharmacy segment within Evernorth ...

For many employers, unions, municipalities and other health plan sponsors that choose to work with Accredo as part of their specialty pharmacy network offering, this represents an opportunity for ...

For many employers, unions, municipalities and other health plan sponsors that choose to work with Accredo as part of their specialty pharmacy network offering, this represents an opportunity for ...

Q1 2024 Earnings Call Transcript May 13, 2024 Verrica Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Hello and welcome to the first quarter 20204 Teva Pharmaceuticals Industries Limited earnings conference call. My name is ...

Your article was successfully shared with the contacts you provided. Corporations flat-out want to move to Texas. The Lone Star state has attracted the most headquarters relocations (209) among US ...

Cigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers including Boehringer Ingelheim, Teva and Alvotech at its Accredo pharmacy. "Not all biosimilars ...

Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S. using its Accredo specialty pharmacy beginning in June ...

Late Thursday, Cigna’s Evernorth unit announced it will be offering the biosimilar of Humira through its Accredo specialty pharmacy beginning in June with zero out-of-pocket costs for most ...

The company said the move should save around $3,500 on average per year for some of the 100,000 Accredo patients currently using either Humira or one of its biosimilars. Perlberg did not provide ...

which operates the Express Scripts pharmacy benefit management company and the Accredo specialty pharmacy business as well as certain other medical care provider services. Across all of its ...

Cigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers including Boehringer Ingelheim, Teva and Alvotech at its Accredo pharmacy. "Not all biosimilars are ...